Overview

Safety Study of FluMist With and Without Ampligen

Status:
Terminated
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate FluMist with and without Ampligen in healthy volunteers.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
AIM ImmunoTech Inc.
Hemispherx Biopharma
Treatments:
Poly I-C
poly(I).poly(c12,U)